therafixx-tusso 0.15 % siroop
haleon belgium sa-nv - butamiraatcitraat 0,15 g/100 ml - siroop - 0,15 % - butamiraatcitraat 1.5 mg/ml - butamirate
pentoxyverine sanofi 2,13 mg/ml or. opl.
opella healthcare belgium sa-nv - pentoxyverinecitraat 2,13 mg/ml - eq. pentoxyverine 1,35 mg/ml - drank - 2,13 mg/ml - pentoxyverinecitraat 2.13 mg/ml - pentoxyverine
lyfnua
merck sharp & dohme b.v. - gefapixant - cough - hoest en verkoudheid - lyfnua is indicated in adults for the treatment of refractory or unexplained chronic cough.
panatus 20 mg filmsko obložene tablete
krka, d.d., novo mesto - butamiratijev citrat - filmsko obložena tableta - butamiratijev citrat 20 mg / 1 tableta - butamirat
panatus forte 7,5 mg/5 ml sirup
krka, d.d., novo mesto - butamiratijev citrat - sirup - butamiratijev citrat 7,5 mg / 5 ml - butamirat
sinecod 7,5 mg/5 ml sirup
glaxosmithkline dungarvan ltd - butamirat - sirup - butamirat 4,6 mg / 5 ml - butamirat
panatus 4 mg/5 ml sirup
krka, d.d., novo mesto - butamiratijev citrat - sirup - butamiratijev citrat 4 mg / 5 ml - butamirat
panatus forte 50 mg filmsko obložene tablete
krka, d.d., novo mesto - butamiratijev citrat - filmsko obložena tableta - butamiratijev citrat 50 mg / 1 tableta - butamirat
sinecod 5 mg/ml peroralne kapljice, raztopina
glaxosmithkline consumer healthcare (uk) trading limited - butamirat - peroralne kapljice, raztopina - butamirat 3,1 mg / 1 ml - butamirat
sinecod 50 mg tablete s podaljšanim sproščanjem
glaxosmithkline consumer healthcare (uk) trading limited - butamirat - tableta s podaljšanim sproščanjem - butamirat 30,7 mg / 1 tableta - butamirat